Annual Total Liabilities
$21.20 M
+$820.00 K+4.02%
December 31, 2023
Summary
- As of March 3, 2025, EWTX annual total liabilities is $21.20 million, with the most recent change of +$820.00 thousand (+4.02%) on December 31, 2023.
- During the last 3 years, EWTX annual total liabilities has fallen by -$143.35 million (-87.11%).
- EWTX annual total liabilities is now -87.11% below its all-time high of $164.56 million, reached on December 31, 2020.
Performance
EWTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$22.41 M
+$1.23 M+5.82%
September 30, 2024
Summary
- As of March 3, 2025, EWTX quarterly total liabilities is $22.41 million, with the most recent change of +$1.23 million (+5.82%) on September 30, 2024.
- Over the past year, EWTX quarterly total liabilities has stayed the same.
- EWTX quarterly total liabilities is now -86.38% below its all-time high of $164.56 million, reached on December 31, 2020.
Performance
EWTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
EWTX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.0% | 0.0% |
| 3 y3 years | -87.1% | 0.0% |
| 5 y5 years | -48.8% | 0.0% |
EWTX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +95.4% | at high | +106.5% |
| 5 y | 5-year | -87.1% | +95.4% | -86.4% | +361.9% |
| alltime | all time | -87.1% | +95.4% | -86.4% | +361.9% |
Edgewise Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $22.41 M(+5.8%) |
| Jun 2024 | - | $21.17 M(+12.2%) |
| Mar 2024 | - | $18.86 M(-11.0%) |
| Dec 2023 | $21.20 M(+4.0%) | $21.20 M(+1.3%) |
| Sep 2023 | - | $20.94 M(+9.2%) |
| Jun 2023 | - | $19.17 M(+9.2%) |
| Mar 2023 | - | $17.56 M(-13.9%) |
| Dec 2022 | $20.39 M | $20.39 M(+29.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $15.75 M(+42.6%) |
| Jun 2022 | - | $11.04 M(-10.9%) |
| Mar 2022 | - | $12.39 M(+14.2%) |
| Dec 2021 | $10.85 M(-93.4%) | $10.85 M(+19.9%) |
| Sep 2021 | - | $9.05 M(+34.3%) |
| Jun 2021 | - | $6.74 M(+38.9%) |
| Mar 2021 | - | $4.85 M(-97.1%) |
| Dec 2020 | $164.56 M(+297.5%) | $164.56 M |
| Dec 2019 | $41.39 M | - |
FAQ
- What is Edgewise Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual total liabilities year-on-year change?
- What is Edgewise Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly total liabilities year-on-year change?
What is Edgewise Therapeutics annual total liabilities?
The current annual total liabilities of EWTX is $21.20 M
What is the all time high annual total liabilities for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual total liabilities is $164.56 M
What is Edgewise Therapeutics annual total liabilities year-on-year change?
Over the past year, EWTX annual total liabilities has changed by +$820.00 K (+4.02%)
What is Edgewise Therapeutics quarterly total liabilities?
The current quarterly total liabilities of EWTX is $22.41 M
What is the all time high quarterly total liabilities for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly total liabilities is $164.56 M
What is Edgewise Therapeutics quarterly total liabilities year-on-year change?
Over the past year, EWTX quarterly total liabilities has changed by $0.00 (0.00%)